Aprogen Pharmaceuticals Inc

KRX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026

Company Profile

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

ExchangeKRX

Market Capitalization22,554 mln

Float6.79 mln

Earnings Date08/18/2025

Piotroski F-Score

4 / 9

Borderline

Beneish M-Score

-2.61

Likely reliable

Relative Strength

18 / 100

Significantly lagging

Debt / Equity

1.09

Elevated leverage

Pre-Tax Margin

-88%

Severely loss-making

ROE

-35.85

Deeply negative

Business Description

Established over six decades ago, Aprogen Biologics Inc. is a Seoul-based company focused on bringing medical treatments to the South Korean market. It develops and distributes a range of pharmaceutical goods to serve patients and healthcare providers across the country.

Key Fundamentals

EPS-5,882

ROE-35.85

RPS6,443

ROIC-19.70

ROA-13.73

Interest Cover-8.02

EBITDA, mln-41,241

EV / EBITDA-6.99

EV / EBIT-4.75

Revenue, mln86,181

EV / Revenue3.35

Quote Details

Last 1,335.00

Change -45 (-3.26%)

Open 1,379.00

Volume 91,793

Turnover 122,543,656

Average Volume 102,989

Financial Ratios

Pre-Tax Profit Margin-88

Leverage Ratio2.82

Current Ratio0.57

Price / Book0.08

Price / Tangible Book0.08

Debt / Equity1.09

Price / Sales0.23

Financial Strength

Altman Z-Score-1.21

Piotroski F-Score 4 / 9

Beneish M-Score-2.61

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-3.75%	36 / 100
1 Month	-11.41%	40 / 100
2 Months	-32.58%	6 / 100
6 Months	-69.82%	2 / 100
1 Year	-85.91%	1 / 100